NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/<i>ß</i>-Catenin Pathway.

Zhou, Jiancheng; Lai, Jiawei; Cheng, Yongyi; Qu, Weixing

NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/ß-Catenin Pathway.

Zhou, Jiancheng; Lai, Jiawei; Cheng, Yongyi; Qu, Weixing.

Afiliación

Zhou J; Department of Urology, Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi, China.
Lai J; Department of Urology, Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi, China.
Cheng Y; Department of Urology, Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi, China.
Qu W; Department of Urology, Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi, China.

Evid Based Complement Alternat Med ; 2022: 1890823, 2022.

Article en En | MEDLINE | ID: mdl-36212952

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Evid Based Complement Alternat Med Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google